| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 14.857 | 28.879 | 26.666 | 22.883 | 19.849 | 14.642 | 17.713 | 18.780 | 18.094 |
| Total Income - EUR | - | 14.910 | 28.930 | 26.712 | 22.942 | 19.921 | 14.720 | 17.713 | 18.798 | 18.094 |
| Total Expenses - EUR | - | 13.211 | 29.270 | 29.099 | 25.657 | 19.659 | 15.019 | 15.861 | 14.987 | 12.007 |
| Gross Profit/Loss - EUR | - | 1.699 | -340 | -2.387 | -2.715 | 262 | -299 | 1.853 | 3.810 | 6.087 |
| Net Profit/Loss - EUR | - | 1.251 | -630 | -2.654 | -2.944 | -290 | -545 | 1.318 | 3.201 | 5.133 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Acvamarin Benefic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 176 | 173 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 5.942 | 6.281 | 5.879 | 4.416 | 2.987 | 3.500 | 6.121 | 9.748 | 12.351 |
| Inventories | - | 5.638 | 5.396 | 5.568 | 4.317 | 1.999 | 3.124 | 5.303 | 9.089 | 11.869 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 440 | 390 |
| Cash | - | 304 | 885 | 311 | 98 | 988 | 376 | 818 | 219 | 93 |
| Shareholders Funds | - | 1.296 | 644 | -2.021 | -4.927 | -5.123 | -5.555 | -4.254 | -1.040 | 4.098 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 4.822 | 5.810 | 7.900 | 9.342 | 8.110 | 9.055 | 10.375 | 10.788 | 8.253 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Acvamarin Benefic Srl